AxonDx Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

AxonDx General Information

Description

Developer of a circulating tumor cells detection device designed to scan all nucleated cells in a blood sample. The company's device scans un-enriched blood samples in minutes, finds all classes of circulating tumor cells shed by solid tumors, and offers a morphological and outsourced molecular characterization of positive cells, enabling cancer patients to self-diagnose early-stage cancer.

Contact Information

Website
www.axondx.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Primary Office
  • 379 Reas Ford Road
  • Suite 1
  • Earlysville, VA 22936
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AxonDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-May-2020 Completed Generating Revenue
To view AxonDx’s complete valuation and funding history, request access »

AxonDx Patents

AxonDx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3602490-A4 Spectral imaging apparatus and methods Inactive 24-Mar-2017 00000000000 0
US-20200018702-A1 Spectral imaging apparatus and methods Active 24-Mar-2017 00000000000
EP-3602490-A1 Spectral imaging apparatus and methods Inactive 24-Mar-2017 00000000000
US-10962478-B2 Spectral imaging apparatus and methods Active 24-Mar-2017 00000000000 00
US-20180328848-A1 Cell detection, capture, analysis, aggregation, and output methods and apparatus Inactive 04-Nov-2015 G01N21/6458
To view AxonDx’s complete patent history, request access »

AxonDx Executive Team (2)

Name Title Board Seat Contact Info
Kent Murphy Ph.D Founder, Chief Executive Officer & President
Phil Couch Ph.D Chief Technology Officer
To view AxonDx’s complete executive team members history, request access »

AxonDx Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Science Foundation Government 000 0000 000000 0
To view AxonDx’s complete investors history, request access »